Survey question: "Are you currently using or have you ever used one of these drugs to lose weight or treat a chronic condition such as diabetes or heart disease? "
Citation formats
Use of GLP-1 for chronic conditions in the U.S. 2024-2025
In a 2025 survey on GLP-1 usage in the United States, ** percent of respondents reported having used or currently using GLP-1 medications to lose weight or treat chronic conditions, representing an increase compared to the previous year. The most commonly prescribed drugs were Ozempic or Wegovy.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
KFF. (December 8, 2025). Use of GLP-1 for weight loss, diabetes, or another chronic condition in the U.S. in May 2024 and November 2025 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 28, 2026, from /statistics/1626359/glp-1-use-for-chronic-conditions-in-the-us/
KFF. "Use of GLP-1 for weight loss, diabetes, or another chronic condition in the U.S. in May 2024 and November 2025." Chart. December 8, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 28, 2026. /statistics/1626359/glp-1-use-for-chronic-conditions-in-the-us/
KFF. (2025). Use of GLP-1 for weight loss, diabetes, or another chronic condition in the U.S. in May 2024 and November 2025. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 28, 2026. /statistics/1626359/glp-1-use-for-chronic-conditions-in-the-us/
KFF. "Use of Glp-1 for Weight Loss, Diabetes, or Another Chronic Condition in The U.S. in May 2024 and November 2025." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 8 Dec 2025, /statistics/1626359/glp-1-use-for-chronic-conditions-in-the-us/
KFF, Use of GLP-1 for weight loss, diabetes, or another chronic condition in the U.S. in May 2024 and November 2025 ÌÇÐÄÆƽâ°æ, /statistics/1626359/glp-1-use-for-chronic-conditions-in-the-us/ (last visited July 28, 2026)
Use of GLP-1 for weight loss, diabetes, or another chronic condition in the U.S. in May 2024 and November 2025 [Graph], KFF, December 8, 2025. [Online]. Available: /statistics/1626359/glp-1-use-for-chronic-conditions-in-the-us/
